Vident Advisory, LLC Novartis Ag Transaction History
Vident Advisory, LLC
- $3.97 Trillion
- Q3 2024
A detailed history of Vident Advisory, LLC transactions in Novartis Ag stock. As of the latest transaction made, Vident Advisory, LLC holds 22,500 shares of NVS stock, worth $2.21 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
22,500
Previous 19,043
18.15%
Holding current value
$2.21 Million
Previous $2.03 Billion
27.66%
% of portfolio
0.07%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.2 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.18 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$796 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$687 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$567 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $212B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...